Citius Oncology annual ebitda
2022
2023
2024
2025
Citius Oncology EBITDA Growth & History (CTOR)
Citius Oncology's calculated EBITDA was −$23.5M for fiscal 2025.
View full Citius Oncology company overviewCitius Oncology annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | −$23.5M | −$2.9M | — |
| 2024 | 2024-09-30 | −$20.6M | −$8.5M | — |
| 2023 · Sep 30 | 2023-09-30 | −$12.1M | −$7.3M | — |
| 2022 | 2022-09-30 | −$4.9M | — | — |
Citius Oncology quarterly ebitda
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | −$6.7M | −$1.8M | — |
| Q2 2026 | 2026-03-31 | −$25.1M | −$17.6M | — |
| Q1 2026 | 2025-12-31 | −$4.7M | — | — |
| Q4 2025 | 2025-09-30 | −$4.7M | — | — |
| Q3 2025 | 2025-06-30 | −$4.9M | — | — |
| Q2 2025 | 2025-03-31 | −$7.5M | — | — |
Citius Oncology ebitda trends
Between the periods ended 2022-09-30 and 2025-09-30, Citius Oncology's ebitda decreased from −$4.9M to −$23.5M, a change of −$18.6M. The latest reported quarter, Q3 2026, shows −$6.7M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Oncology source filings ↗Community posts
Citius Oncology’s wholesaler shipments rise sharply while institutional orders grow modestly
Citius Oncology ($CTOR) reported preliminary sales of 792 Lymphir units to US wholesalers for its fiscal fourth quarter of 2026, up 120% from 360 in the preceding quarter. Separately, prescribing centers ordered 950 vials from wholesalers, ...
